Down-regulation of PVT1 could reduce proinflammatory cytokines, MMP-2 and MMP-9, increase TIMP-1, and further reverse angiotensin II-induced AAA-associated alterations in mice [11]. Here, MMP9 is linked to triple-A syndrome.